GORMAN KEVIN CHARLES bought NBIX
January 9, 2024 · Form 4 insider transaction
GORMAN KEVIN CHARLES bought 62,023 shares of Neurocrine Biosciences, Inc. at $19.59 per share, a transaction worth $1.22M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
62,023
Price
$19.59
Total value
$1.22M
InsiderGORMAN KEVIN CHARLES
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 9, 2024
Filing dateJanuary 10, 2024
Shares owned after561,777
OwnershipDirect
10b5-1 planNo
AmendedNo